Swallowing difficulty and drugs of ingredients of sodium oxybate - a phase IV clinical study of FDA data
Summary:
Swallowing difficulty is found among people who take drugs with ingredients of sodium oxybate, especially for people who are female, 40-49 old , have been taking the drugs for < 1 month. This phase IV clinical study is created by eHealthMe based on reports of 74,129 people who have side effects when taking drugs with ingredients of sodium oxybate from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Xyrem.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
74,129 people reported to have side effects when taking drugs with ingredients of sodium oxybate.
Among them, 257 people (0.35%) have Swallowing difficulty
What is Swallowing difficulty?
Swallowing difficulty is found to be associated with 3,630 drugs and 3,210 conditions by eHealthMe.
Number of reports submitted per year:
Time on drugs with ingredients of sodium oxybate when people have Swallowing difficulty *:
- < 1 month: 56.57 %
- 1 - 6 months: 26.26 %
- 6 - 12 months: 5.05 %
- 1 - 2 years: 4.04 %
- 2 - 5 years: 6.06 %
- 5 - 10 years: 2.02 %
- 10+ years: 0.0 %
Gender of people who have Swallowing difficulty when taking drugs with ingredients of sodium oxybate *:
- female: 84.71 %
- male: 15.29 %
Age of people who have Swallowing difficulty when taking drugs with ingredients of sodium oxybate *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 7.3 %
- 20-29: 11.24 %
- 30-39: 23.03 %
- 40-49: 30.9 %
- 50-59: 20.79 %
- 60+: 6.74 %
Conditions people have *:
- Drowsiness: 22 people, 8.56%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 5.45%
- High Blood Pressure: 13 people, 5.06%
- Stress And Anxiety: 11 people, 4.28%
- Depression: 10 people, 3.89%
- High Blood Cholesterol: 10 people, 3.89%
- Fibromyalgia (a long-term condition which causes pain all over the body): 10 people, 3.89%
- Pain: 9 people, 3.50%
- Hypersensitivity: 9 people, 3.50%
- Bipolar Disorder (mood disorder): 9 people, 3.50%
Other drugs people take *:
- Adderall: 68 people, 26.46%
- Vitamin D3: 38 people, 14.79%
- Nuvigil: 34 people, 13.23%
- Cymbalta: 30 people, 11.67%
- Lyrica: 23 people, 8.95%
- Linzess: 20 people, 7.78%
- Synthroid: 20 people, 7.78%
- Vyvanse: 18 people, 7.00%
- Lamictal: 17 people, 6.61%
- Norco: 15 people, 5.84%
Other side effects people have besides Swallowing difficulty *:
- Stress And Anxiety: 62 people, 24.12%
- Nausea (feeling of having an urge to vomit): 50 people, 19.46%
- Weight Decreased: 50 people, 19.46%
- Headache (pain in head): 47 people, 18.29%
- Fatigue (feeling of tiredness): 47 people, 18.29%
- Dizziness: 44 people, 17.12%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 43 people, 16.73%
- Tremor (trembling or shaking movements in one or more parts of your body): 40 people, 15.56%
- Feeling Abnormal: 35 people, 13.62%
- Breathing Difficulty: 34 people, 13.23%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Drugs with ingredients of sodium oxybate, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on sodium oxybate. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Nateglinide and Soft Tissue Necrosis - 10 seconds ago
- Propoxyphene Hydrochloride vs. Carbamazepine - 15 seconds ago
- Lipidil and Speech Impairment (Adult) - 18 seconds ago
- Zenatane and Ativan drug interaction - 21 seconds ago
- Colace and Muscle Function Loss - 38 seconds ago
- Inner Ear Inflammation and Insomnia - 41 seconds ago
- Antabuse and Headache - 46 seconds ago
- Sevelamer Hydrochloride and Upper Respiratory Tract Inflammation - 59 seconds ago
- Elavil and Cerebral Small Vessel Ischaemic Disease - a minute ago
- Lexapro vs. Tranylcypromine Sulfate - a minute ago